CSI Market
Sign In | Register

10x Genomics Inc (TXG) Annual Balance Sheets

Annual · GAAP · USD millions
Access TXG quarterly Balance Sheets →
The data below summarizes 10x Genomics Inc's balance sheet position from Dec 31 2021 to Dec 31 2025, enabling a period-by-period comparison of financial strength.
View historic periods: Download as CSV:
Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.
Annual Report, GAAP in USD millions
ITEM 		(Dec 31 2025)
(Dec 31 2024) (Dec 31 2023) (Dec 31 2022) (Dec 31 2021)
Assets
Cash & cash equivalent473.97
Available-for-sale Securities, Debt Securities, Current MA49.44
Cash & Short-term Investments522.00
Accounts receivable47.01
Other Receivables, Net, Current35.48
Inventories56.34
Prepaid Expense And Other Assets Current22.21
Total Current Assets684.45
Equipment/Property/Plant Net226.71
Goodwill net4.51
Intangible Assets62.33
Tax Assets, Noncurrent0.00
Other Assets, Noncurrent63.36
Restricted Cash Current-
Restricted Cash Noncurrent-
Total Assets1,041.37
Liabilities
Accounts Payable, Current AC12.73
Employee-related Liabilities, Current AC42.50
Estimated Litigation Liability, Current23.36
Other Liabilities, Current74.86
Taxes Payable0.00
Total Current Liabilities153.45
Total Long-term Debt0.00
Estimated Litigation Liability, Noncurrent LI1.24
Accrued Income Taxes, Noncurrent0.00
Other liabilities, Noncurrent6.47
Accrued Expenses and Other Liabilities Current-
Contract With Customer Liability Current23.90
Accrued Contingent Liabilities Noncurrent-
Contract With Customer Liability Noncurrent10.50
Operating Lease Liability Noncurrent73.38
License Fees Accrued Noncurrent-
Total Liabilities245.04
Stockholders' Equity
Common Stock Value0.00
Additional Paid In Capital Common Stock2,306.69
Retained Earnings / Accumulated Deficit-1,510.59
Accumulated Other Comprehensive Income0.00
Other Equity0.22
Common Stockholder's Equity796.33
Total Stockholder's Equity796.33
Liabilities & Stockholder's Equity1,041.37
4 historic quarters locked

Sign in to unlock the full 10x Genomics Inc balance sheet history.

Sign In Create Free Account

About 10x Genomics Inc Annual Balance Sheet

What this statement shows

This page presents issuer-reported balance sheet data, detailing assets, liabilities, and stockholders equity as reported in SEC 10-K filings and standardized by CSIMarket. The balance sheet reflects the company's financial position at the end of each reporting period.

Source & verification

  • Form: 10-K (Period: 20251231)
  • Filed with the SEC: February 12, 2026
  • Source: txg-20251231.htm

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - balance-sheet normalization in the CSIMarket.com financial database.
  • Accession: 0001628280-26-007822

Balance sheet figures represent financial position at specific reporting dates and may be revised in subsequent filings.

Get the full CSIMarket dataset: Subscribe API License